Evidence map›Paper›PMID 24320011›Full record

ArticleAIDS patient care and STDs2013

Early warning indicators for first-line virologic failure independent of adherence measures in a South African urban clinic.

Vincent C Marconi, Baohua Wu, Jane Hampton, Claudia E Ordóñez, Brent A Johnson, Dinesh Singh, Sally John, Michelle Gordon, Anna Hare, Richard Murphy and 5 more

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in AIDS patient care and STDs, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03438370 (Outcomes of Differentiated Models of Antiretroviral Treatment), which is not on this map. Cited by 34 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 4 pooled it
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03438370 naunknown statusnot on this mapstarted 2017, after this paper: background citation

Outcomes of Differentiated Models of Antiretroviral Treatment (ART) Provision: Multi-Month Dispensing (MMD) of ART in Community ART Distribution for Stable HIV Infected Patients

TypeinterventionalSponsorEquip, LesothoRan2017 to 2019Enrolled5,760ConditionsHIV/AIDSArmsThree monthly ART supply at CAGs, Six monthly ART supply at outreaches
3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 4 syntheses or guidelines pooled it, 51 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. A Critical Review of Symptom Management Nursing Science on HIV-Related Fatigue and Sleep Disturbance.International journal of environmental research and public health · 2021
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 2 countries.

Vincent C Marconi1 Department of Medicine/Infectious Disease, School of Medicine, Emory University , Atlanta, Georgia .
Baohua Wu
Jane Hampton
Claudia E Ordóñez
Brent A Johnson
Dinesh Singh
Sally John
Michelle Gordon
Anna Hare
Richard Murphy
Jean Nachega
Daniel R Kuritzkes
Carlos del Rio
Henry Sunpath
South Africa Resistance Cohort Study Team Group Authors
McCord Hospital · ZAEmory University · USBrigham and Women's Hospital · USMédecins Sans Frontières · USVeterans Health Administration · USWestern Cape Department of Health · ZA

Funding

The impact of HIV viral diversity and cellular immunity on HIV pathogenesisP30AI060354 · NIAID · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI ARTHUR Y KIM · 2004 to 2026
$94.4M
Virology and Molecular Biomarkers CoreP30AI050409 · NIAID · EMORY UNIVERSITY · PI Ann M Chahroudi, Colleen F Kelley · 2002 to 2026
$74.0M
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCHUL1RR025008 · NCRR · EMORY UNIVERSITY · PI STEPHENS, DAVID S · 2007 to 2011
$29.0M
Atlanta Clinical and Translational Science Institute (ACTSI) RenewalUL1TR000454 · NCATS · EMORY UNIVERSITY · PI STEPHENS, DAVID S · 2012 to 2016
$25.8M
HIV-1 THERAPEUTICS AND DRUG RESISTANCEK24RR016482 · NCRR · UNIVERSITY OF COLORADO DENVER · PI KURITZKES, DANIEL R. · 2001 to 2010
$1.0M
NCATS NIH HHS UL1 TR000454NCRR NIH HHS K24 RR16482NCRR NIH HHS UL1RR025008NIAID NIH HHS P30 AI050409NIAID NIH HHS P30 AI60354PHS HHS U62/CCU123541-01
6 · The paper itself

Abstract

We sought to develop individual-level Early Warning Indicators (EWI) of virologic failure (VF) for clinicians to use during routine care complementing WHO population-level EWI. A case-control study was conducted at a Durban clinic. Patients after ≥ 5 months of first-line antiretroviral therapy (ART) were defined as cases if they had VF [HIV-1 viral load (VL)>1000 copies/mL] and controls (2:1) if they had VL ≤ 1000 copies/mL. Pharmacy refills and pill counts were used as adherence measures. Participants responded to a questionnaire including validated psychosocial and symptom scales. Data were also collected from the medical record. Multivariable logistic regression models of VF included factors associated with VF (p<0.05) in univariable analyses. We enrolled 158 cases and 300 controls. In the final multivariable model, male gender, not having an active religious faith, practicing unsafe sex, having a family member with HIV, not being pleased with the clinic experience, symptoms of depression, fatigue, or rash, low CD4 counts, family recommending HIV care, and using a TV/radio as ART reminders (compared to mobile phones) were associated with VF independent of adherence measures. In this setting, we identified several key individual-level EWI associated with VF including novel psychosocial factors independent of adherence measures.

Indexed as

Antiretroviral Therapy, Highly ActiveMedication AdherenceAdultAmbulatory Care FacilitiesAnti-HIV AgentsCase-Control StudiesCD4 Lymphocyte CountDrug Resistance, ViralFemaleHealth Services AccessibilityHIV-1HIV InfectionsHumansLogistic ModelsMalePopulation SurveillanceAnti-HIV Agents

Identifiers

PMID24320011
PMCPMC3868291
OpenAlexW2118826232

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.